aplastic anemia | Page 19 | Aplastic Anemia & MDS International Foundation

aplastic anemia

Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia

Author(s): 
Guo Z, Gao HY, Zhang TY, Liu XD, Yang K, Lou JX, He XP, Zhang Y, Chen P, Chen HR
Primary Author: 
Guo Z
Journal Title: 
Int J Hematol
Original Publication Date: 
Oct 2016

The study was aimed to explore the efficacy and safety of allo-HSCT with high-dose

Bone Marrow Diseases: 

Recipient-derived EBV-positive Monomorphic Plasmacytoma Type Posttransplant Lymphoproliferative Disorder After Allogeneic Stem Cell Transplant for Severe Aplastic Anemia: A Case Report

Author(s): 
Carden MA, Caltharp S, Yee ME, Haight AE, Westblade LF, Park S
Primary Author: 
Carden MA
Journal Title: 
J Pediatr Hematol Oncol
Original Publication Date: 
Nov 2016

Monomorphic plasmacytoma-type posttransplant lymphoproliferative disorder (PTLD) has not been reported after pediatric hematopoietic stem cell transplantation. We present a child with hepatitis-associated severe

Bone Marrow Diseases: 

Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?

Author(s): 
Gallo S, Woolfrey AE, Burroughs LM, Storer BE, Flowers ME, Hari P, Pulsipher MA, Heimfeld S, Kiem HP, Sandmaier BM, Storb R
Primary Author: 
Gallo S
Journal Title: 
Bone Marrow Transplant
Original Publication Date: 
Aug 2016

A total of 21 patients with severe

Bone Marrow Diseases: